These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Kühl U; Pauschinger M; Schwimmbeck PL; Seeberg B; Lober C; Noutsias M; Poller W; Schultheiss HP Circulation; 2003 Jun; 107(22):2793-8. PubMed ID: 12771005 [TBL] [Abstract][Full Text] [Related]
27. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis. Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735 [TBL] [Abstract][Full Text] [Related]
29. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169 [TBL] [Abstract][Full Text] [Related]
31. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Seferović PM; Paulus WJ Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006 [TBL] [Abstract][Full Text] [Related]
32. High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration. Frustaci A; Francone M; Petrosillo N; Chimenti C Eur J Heart Fail; 2013 Mar; 15(3):284-91. PubMed ID: 23112000 [TBL] [Abstract][Full Text] [Related]
33. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart. Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503 [TBL] [Abstract][Full Text] [Related]
34. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Hasegawa K; Fujiwara H; Doyama K; Mukoyama M; Nakao K; Fujiwara T; Imura H; Kawai C Am J Pathol; 1993 Jan; 142(1):107-16. PubMed ID: 8424448 [TBL] [Abstract][Full Text] [Related]
35. Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. Crespo MJ; Zalacaín J; Dunbar DC; Cruz N; Arocho L J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):64-71. PubMed ID: 18287592 [TBL] [Abstract][Full Text] [Related]
36. Relation of myocardial histomorphometric features and left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Otasević P; Popović ZB; Vasiljević JD; Vidaković R; Pratali L; Vlahović A; Nesković AN Eur J Heart Fail; 2005 Jan; 7(1):49-56. PubMed ID: 15642531 [TBL] [Abstract][Full Text] [Related]
37. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195 [TBL] [Abstract][Full Text] [Related]
38. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Aoki J; Ikari Y; Nakajima H; Mori M; Sugimoto T; Hatori M; Tanimoto S; Amiya E; Hara K Kidney Int; 2005 Jan; 67(1):333-40. PubMed ID: 15610259 [TBL] [Abstract][Full Text] [Related]